{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T03:12:58Z","timestamp":1773371578721,"version":"3.50.1"},"reference-count":50,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T00:00:00Z","timestamp":1762560000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K16454"],"award-info":[{"award-number":["20K16454"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jpba.2025.117242","type":"journal-article","created":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T06:55:37Z","timestamp":1762671337000},"page":"117242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Development of an LC-MS\/MS method for the quantification of sunitinib and its metabolites in human nail and skin"],"prefix":"10.1016","volume":"269","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0474-2007","authenticated-orcid":false,"given":"Miki Takenaka","family":"Sato","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9162-5405","authenticated-orcid":false,"given":"Takuya","family":"Araki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8982-2312","authenticated-orcid":false,"given":"Hideaki","family":"Yashima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4857-8683","authenticated-orcid":false,"given":"Jun","family":"Morita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9914-6242","authenticated-orcid":false,"given":"Yoshiko","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9862-2400","authenticated-orcid":false,"given":"Masayuki","family":"Ohbayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4681-5833","authenticated-orcid":false,"given":"Noriko","family":"Kohyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9542-2924","authenticated-orcid":false,"given":"Yoshio","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0261-6303","authenticated-orcid":false,"given":"Takashi","family":"Fukagai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koujirou","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7553-0872","authenticated-orcid":false,"given":"Mari","family":"Kogo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpba.2025.117242_bib1","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.2165\/00003495-200666170-00007","article-title":"Sunitinib","volume":"66","author":"Deeks","year":"2006","journal-title":"Drugs"},{"key":"10.1016\/j.jpba.2025.117242_bib2","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.clinthera.2007.07.022","article-title":"Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumors","volume":"29","author":"Adams","year":"2007","journal-title":"Clin. Ther."},{"key":"10.1016\/j.jpba.2025.117242_bib3","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1124\/dmd.111.042853","article-title":"Pharmacokinetics, distribution, and metabolism of [14C]sunitinib in rats, monkeys, and humans","volume":"40","author":"Speed","year":"2012","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.jpba.2025.117242_bib4","first-page":"19","article-title":"The impact of sunitinib N-oxide as a photodegradation product of sunitinib","volume":"1","author":"Takenaka","year":"2019","journal-title":"Indones. J. Pharm."},{"key":"10.1016\/j.jpba.2025.117242_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.clgc.2015.01.007","article-title":"Assessment of sunitinib-induced toxicities and clinical outcomes based on therapeutic drug monitoring of sunitinib for patients with renal cell carcinoma","volume":"13","author":"Noda","year":"2015","journal-title":"Clin. Genitourin. Cancer"},{"key":"10.1016\/j.jpba.2025.117242_bib6","doi-asserted-by":"crossref","first-page":"25277","DOI":"10.18632\/oncotarget.25423","article-title":"Clinical implications of pharmacokinetics of sunitinib malate and N-desethyl-sunitinib plasma concentrations for treatment outcome in metastatic renal cell carcinoma patients","volume":"9","author":"Numakura","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/j.jpba.2025.117242_bib7","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s10147-018-1302-7","article-title":"Relationships between sunitinib plasma concentration and clinical outcomes in Japanese patients with metastatic renal cell carcinoma","volume":"23","author":"Takasaki","year":"2018","journal-title":"Int. J. Clin. Oncol."},{"key":"10.1016\/j.jpba.2025.117242_bib8","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/cpt.787","article-title":"Practical Recommendations for Therapeutic Drug Monitoring of Kinase Inhibitors in Oncology","volume":"102","author":"Verheijen","year":"2017","journal-title":"Clin. Pharm. Ther."},{"key":"10.1016\/j.jpba.2025.117242_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.critrevonc.2017.09.016","article-title":"Hand-foot skin reaction with vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: A systematic review and meta-analysis","volume":"119","author":"Li","year":"2017","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.jpba.2025.117242_bib10","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/j.1529-8019.2011.01435.x","article-title":"Cutaneous toxicities of the multikinase inhibitors sorafenib and sunitinib","volume":"24","author":"McLellan","year":"2011","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.jpba.2025.117242_bib11","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1159\/000258880","article-title":"Hand-foot syndrome (hand-foot skin reaction, palmar-plantar erythrodysesthesia): focus on sorafenib and sunitinib","volume":"77","author":"Lipworth","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jpba.2025.117242_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1080\/17512433.2019.1689122","article-title":"Sorafenib-associated hand-foot skin reaction: practical advice on diagnosis, mechanism, prevention, and management","volume":"12","author":"Ai","year":"2019","journal-title":"Expert Rev. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117242_bib13","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1001\/archderm.1997.03890430123017","article-title":"Antineoplastic chemotherapy, sweat, and the skin","volume":"133","author":"Horn","year":"1997","journal-title":"Arch. Dermatol. J."},{"key":"10.1016\/j.jpba.2025.117242_bib14","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1200\/JCO.2006.08.9565","article-title":"Hand-foot and stump syndrome to sorafenib","volume":"25","author":"Lai","year":"2007","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jpba.2025.117242_bib15","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1007\/s00228-013-1579-4","article-title":"The effect of seasonal variation and secretion of sunitinib in sweat on the development of hand-foot syndrome","volume":"69","author":"Lankheet","year":"2013","journal-title":"Eur. J. Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117242_bib16","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1093\/annonc\/mdr580","article-title":"Development and validation of a prediction index for hand-foot skin reaction in cancer patients receiving sorafenib","volume":"23","author":"Dranitsaris","year":"2012","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jpba.2025.117242_bib17","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/bjc.2012.287","article-title":"Sorafenib in advanced melanoma: a critical role for pharmacokinetics?","volume":"107","author":"P\u00e9cuchet","year":"2012","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.jpba.2025.117242_bib18","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042875","article-title":"Early sorafenib-induced toxicity is associated with drug exposure and UGTIA9 genetic polymorphism in patients with solid tumors: a preliminary study","volume":"7","author":"Boudou-Rouquette","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jpba.2025.117242_bib19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2165\/00003088-200038020-00001","article-title":"Drugs in nails: physiology, pharmacokinetics and forensic toxicology","volume":"38","author":"Palmeri","year":"2000","journal-title":"Clin. Pharm."},{"key":"10.1016\/j.jpba.2025.117242_bib20","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/dta.1991","article-title":"Time-course measurements of drug concentrations in hair and toenails after single administrations of pharmaceutical products","volume":"9","author":"Kuwayama","year":"2017","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2025.117242_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.envpol.2025.125784","article-title":"Application of nail analysis in human biomonitoring of toxic pollutants: a review","volume":"368","author":"Li","year":"2025","journal-title":"Environ. Pollut."},{"key":"10.1016\/j.jpba.2025.117242_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2021.111028","article-title":"Toxic metals in toenails as biomarkers of exposure: A review","volume":"197","author":"Salcedo-Bellido","year":"2021","journal-title":"Environ. Res."},{"key":"10.1016\/j.jpba.2025.117242_bib23","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1002\/dta.3748","article-title":"Current status of keratinized matrices in Toxicology: comparison of hair and nails","volume":"17","author":"Cobo-Golpe","year":"2025","journal-title":"Drug Test. Anal."},{"key":"10.1016\/j.jpba.2025.117242_bib24","article-title":"Investigation on utility of some novel terpenes on transungual delivery of terbinafine for the management of Onychomycosis","volume":"12","author":"Gupta","year":"2022","journal-title":"Dermatol. Pract. Concept"},{"key":"10.1016\/j.jpba.2025.117242_bib25","first-page":"68","article-title":"Development of a quantitative method for sunitinib N-oxide","volume":"3","author":"Ishikawa","year":"2021","journal-title":"Indones. J. Pharm."},{"key":"10.1016\/j.jpba.2025.117242_bib26","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1097\/FTD.0000000000001097","article-title":"An optimized LC-MS\/MS method for quantification of sunitinib and N-desethyl sunitinib in human plasma and its application for therapeutic drug monitoring","volume":"45","author":"Li","year":"2023","journal-title":"Ther. Drug Monit."},{"issue":"11\u201312","key":"10.1016\/j.jpba.2025.117242_bib27","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.jchromb.2011.02.006","article-title":"Development and validation of a liquid chromatography\/tandem mass spectrometry procedure for the quantification of sunitinib (SU11248) and its active metabolite, N-desethyl sunitinib (SU12662), in human plasma: application to an explorative study","volume":"879","author":"Rodamer","year":"2011","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2025.117242_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2019.112949","article-title":"A new high-performance liquid chromatography-tandem mass spectrometry method for the determination of sunitinib and N-desethyl sunitinib in human plasma: Light-induced isomerism overtaking towards therapeutic drug monitoring in clinical routine","volume":"179","author":"Marangon","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117242_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2024.124100","article-title":"Simultaneous determination of 11 oral targeted antineoplastic drugs and 2 active metabolites by LC-MS\/MS in human plasma and its application to therapeutic drug monitoring in cancer patients","volume":"1237","author":"Zhao","year":"2024","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2025.117242_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2021.114562","article-title":"Method development and validation for simultaneous determination of six tyrosine kinase inhibitors and two active metabolites in human plasma\/serum using UPLC-MS\/MS for therapeutic drug monitoring","volume":"211","author":"Zhang","year":"2022","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117242_bib31","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1097\/FTD.0000000000001175","article-title":"Analytical validation of a volumetric absorptive microsampling method for therapeutic drug monitoring of the oral targeted anticancer agents, abiraterone, alectinib, cabozantinib, imatinib, olaparib, and sunitinib, and metabolites","volume":"46","author":"Meertens","year":"2024","journal-title":"Ther. Drug Monit."},{"issue":"23\u201324","key":"10.1016\/j.jpba.2025.117242_bib32","article-title":"Sunitinib LC-MS\/MS assay in mouse plasma and brain tissue: application in CNS distribution studies","volume":"76","author":"Oberoi","year":"2013","journal-title":"Chromatographia"},{"key":"10.1016\/j.jpba.2025.117242_bib33","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.jpba.2009.10.006","article-title":"Quantification of sunitinib in mouse plasma, brain tumor and normal brain using liquid chromatography-electrospray ionization-tandem mass spectrometry and pharmacokinetic application","volume":"51","author":"Zhou","year":"2010","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117242_bib34","first-page":"166","article-title":"The influence of the time-of-day administration of sunitinib on the penetration through the blood-brain and blood-aqueous humour barriers in rabbits","volume":"20","author":"Soba\u0144ska","year":"2016","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"10.1016\/j.jpba.2025.117242_bib35","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1439-0507.2007.01438.x","article-title":"Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis","volume":"51","author":"Kikuchi","year":"2008","journal-title":"Mycoses"},{"key":"10.1016\/j.jpba.2025.117242_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2023.115557","article-title":"Determination of ten antipsychotics in blood, hair and nails: Validation of a LC-MS\/MS method and forensic application of keratinized matrix analysis","volume":"234","author":"Yang","year":"2023","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117242_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpba.2020.113443","article-title":"Determination of antipsychotic drugs in nails and hair by liquid chromatography tandem mass spectrometry and evaluation of their incorporation into keratinized matrices","volume":"189","author":"Cobo-Golpe","year":"2020","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117242_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.forsciint.2021.110935","article-title":"Determination of antidepressants and benzodiazepines in paired hair and nail samples","volume":"326","author":"Cobo-Golpe","year":"2021","journal-title":"Forensic Sci. Int."},{"key":"10.1016\/j.jpba.2025.117242_bib39","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4155\/bio.09.159","article-title":"Determination of tigecycline in human skin using a novel validated LC-MS\/MS method","volume":"2","author":"Ji","year":"2010","journal-title":"Bioanalysis"},{"key":"10.1016\/j.jpba.2025.117242_bib40","first-page":"375","article-title":"Clinical characteristics, treatment outcomes, and prognosis in patients with MKIs-associated hand-foot skin reaction: a retrospective study","volume":"31","author":"Shou","year":"2023","journal-title":"Support. Care Cancer"},{"key":"10.1016\/j.jpba.2025.117242_bib41","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1093\/annonc\/mdn389","article-title":"Hand foot skin reaction in cancer patients treated with the multikinase inhibitors sorafenib and sunitinib","volume":"19","author":"Lacouture","year":"2008","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.jpba.2025.117242_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2022.123354","article-title":"Development and validation of a high-performance liquid chromatography tandem mass spectrometry method for the quantification of the antiparasitic and antifungal drug amphotericin B in human skin tissue","volume":"1206","author":"Roseboom","year":"2022","journal-title":"J. Chromatogr. B Anal. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.jpba.2025.117242_bib43","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jpba.2003.08.017","article-title":"Simultaneous determination of Z-SU5416 and its interconvertible geometric E-isomer in rat plasma by LC\/MS\/MS","volume":"35","author":"Zhao","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.jpba.2025.117242_bib44","unstructured":"U.S. Food and Drug Administration, Bioanalytical method validation guidance for industry. \u3008https:\/\/www.fda.gov\/files\/drugs\/published\/Bioanalytical-Method-Validation-Guidance-for-Industry.pdf\u3009, 2018 (accessed 10 Aug 2025)."},{"key":"10.1016\/j.jpba.2025.117242_bib45","unstructured":"The International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, Bioanalytical method validation and study sample analysis M10. \u3008https:\/\/database.ich.org\/sites\/default\/files\/M10_Guideline_Step4_2022_0524.pdf\u3009, 2022 (accessed 10 Aug 2025)."},{"key":"10.1016\/j.jpba.2025.117242_bib46","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1080\/00498254.2024.2333007","article-title":"Preclinical pharmacokinetic investigation of the bioavailability and skin distribution of HY-072808 ointment, a novel drug candidate for the treatment of atopic dermatitis, in minipigs by a newly LC-MS\/MS method","volume":"54","author":"Shao","year":"2024","journal-title":"Xenobiotica"},{"key":"10.1016\/j.jpba.2025.117242_bib47","doi-asserted-by":"crossref","first-page":"104","DOI":"10.18433\/J3201Z","article-title":"The tape-stripping technique as a method for drug quantification in skin","volume":"11","author":"Escobar-Ch\u00e1vez","year":"2008","journal-title":"J. Pharm. Pharm. Sci."},{"key":"10.1016\/j.jpba.2025.117242_bib48","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/978-1-0716-1518-8_2","article-title":"Oral Sampling Techniques","volume":"2327","author":"Hussein","year":"2021","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.jpba.2025.117242_bib49","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s12024-016-9801-1","article-title":"The use of nails as an alternative matrix for the long-term detection of previous drug intake: validation of sensitive UHPLC-MS\/MS methods for the quantification of 76 substances and comparison of analytical results for drugs in nail and hair samples","volume":"12","author":"Krumbiegel","year":"2016","journal-title":"Forensic Sci. Med. Pathol."},{"key":"10.1016\/j.jpba.2025.117242_bib50","doi-asserted-by":"crossref","first-page":"2738","DOI":"10.1128\/AAC.39.12.2738","article-title":"Multiple-dose pharmacokinetics and distribution in tissue of terbinafine and metabolites","volume":"39","author":"Kovarik","year":"1995","journal-title":"Antimicrob. Agents Chemother."}],"container-title":["Journal of Pharmaceutical and Biomedical Analysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0731708525005837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T16:22:35Z","timestamp":1773332555000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0731708525005837"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":50,"alternative-id":["S0731708525005837"],"URL":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117242","relation":{},"ISSN":["0731-7085"],"issn-type":[{"value":"0731-7085","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an LC-MS\/MS method for the quantification of sunitinib and its metabolites in human nail and skin","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical and Biomedical Analysis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpba.2025.117242","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"117242"}}